✓Expert Reviewed📅Updated April 2026🔒Independently Researched
Found vs MEDVi
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
7.6
Found
Best for mainstream telehealth GLP-1 accessStarting at $129/mo
CompoundedSemaglutideTirzepatide
Visit Found →7.2
MEDVi
Best for mainstream telehealth GLP-1 accessStarting at $179/mo
CompoundedSemaglutideTirzepatide
Visit MEDVi →Side-by-Side Comparison
| Feature | Found | MEDVi |
|---|---|---|
| Overall Score | ✓7.6/10 | 7.2/10 |
| Starting Price | ✓$129/mo | $179/mo |
| Customer Rating | — | — |
| Features | 3 features | 3 features |
| States Available | 50 | 50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Found
Pros
- ✓Aggressively low monthly pricing
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
MEDVi
Pros
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
Our Verdict
Winner: FoundScore: 7.6/10
Found edges out MEDVi with a higher overall score of 7.6/10 and is particularly strong for mainstream telehealth GLP-1 access. MEDVi remains a solid alternative, especially if you're looking for mainstream telehealth GLP-1 access.